Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Post by Pareto8020on Jun 19, 2024 10:50am
151 Views
Post# 36095888

Happy Anniversary Howard

Happy Anniversary Howard

I missed congratulating Howard on the June 13th 2022 anniversary of the AbbVie deal.  

That was a real watershed for Sirona.  Howard with next to no funds in the SBM coffers thought it would be a great idea to skip any kind of significant upfront and go for a higher royalty rate.  So much so he even convinced the board to accept that setup.  

Then the deal is announced with ZERO details and I mean ZERO details.  Howard thought the market wouldn't mind that and anticipated the stock would be shooting through the roof and was already planning out hiring additional staff, ordering new equipment, etc.

Here we are TWO years later and all Howard has from AbbVie is a selfie from a convention.  The best news they could announce is Howard is finally getting out of the way and letting this ship be guided by a competent captain.  Tech and science is there ...... management has proven they are incompetent at best.

<< Previous
Bullboard Posts
Next >>